These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 641815)

  • 1. Theoretical relationships between area under the curve and route of administration of drugs and their precursors for evaluating sites and pathways of metabolism.
    Pang KS; Gillette JR
    J Pharm Sci; 1978 May; 67(5):703-4. PubMed ID: 641815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic model of presystemic metabolism.
    Colburn WA; Gibaldi M
    Drug Metab Dispos; 1978; 6(2):193-6. PubMed ID: 26536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug.
    Klippert PJ; Noordhoek J
    Drug Metab Dispos; 1985; 13(1):97-101. PubMed ID: 2858385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological modeling to understand the impact of enzymes and transporters on drug and metabolite data and bioavailability estimates.
    Sun H; Pang KS
    Pharm Res; 2010 Jul; 27(7):1237-54. PubMed ID: 20372987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-pass elimination. Basic concepts and clinical consequences.
    Pond SM; Tozer TN
    Clin Pharmacokinet; 1984; 9(1):1-25. PubMed ID: 6362950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacokinetic model to differentiate preabsorptive, gut epithelial, and hepatic first-pass metabolism.
    Colburn WA
    J Pharmacokinet Biopharm; 1979 Aug; 7(4):407-15. PubMed ID: 512846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ratio of first to zeroth moments of the plasma profile of an oral drug undergoing first-pass and linear reversible metabolism.
    Cheng H
    Biopharm Drug Dispos; 1995 Dec; 16(9):791-6. PubMed ID: 8580402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical consideration of the properties of intestinal flow models on route-dependent drug removal: Segregated Flow (SFM) vs. Traditional (TM).
    Noh K; Pang KS
    Biopharm Drug Dispos; 2019 May; 40(5-6):195-213. PubMed ID: 31099032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolite pharmacokinetics: the area under the curve of metabolite and the fractional rate of metabolism of a drug after different routes of administration for renally and hepatically cleared drugs and metabolites.
    Pang KS
    J Pharmacokinet Biopharm; 1981 Aug; 9(4):477-87. PubMed ID: 7310645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of administration route and blood sampling site on the area under the curve. Assessment of gut wall, liver, and lung metabolism from a physiological model.
    Klippert PJ; Noordhoek J
    Drug Metab Dispos; 1983; 11(1):62-6. PubMed ID: 6132799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presystemic extraction: mechanisms and consequences.
    Greenblatt DJ
    J Clin Pharmacol; 1993 Jul; 33(7):650-6. PubMed ID: 8366190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral bioavailability and first-pass effects.
    Kwan KC
    Drug Metab Dispos; 1997 Dec; 25(12):1329-36. PubMed ID: 9394021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro-in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications.
    Cho HJ; Kim JE; Kim DD; Yoon IS
    Drug Dev Ind Pharm; 2014 Aug; 40(8):989-98. PubMed ID: 23981203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Wall Metabolism. Application of Pre-Clinical Models for the Prediction of Human Drug Absorption and First-Pass Elimination.
    Jones CR; Hatley OJ; Ungell AL; Hilgendorf C; Peters SA; Rostami-Hodjegan A
    AAPS J; 2016 May; 18(3):589-604. PubMed ID: 26964996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of ignoring extraction ratio when predicting drug-drug interactions, fraction metabolized, and intestinal first-pass contribution.
    Kirby BJ; Unadkat JD
    Drug Metab Dispos; 2010 Nov; 38(11):1926-33. PubMed ID: 20724498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs.
    Tronde A; Nordén B; Marchner H; Wendel AK; Lennernäs H; Bengtsson UH
    J Pharm Sci; 2003 Jun; 92(6):1216-33. PubMed ID: 12761811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary: theoretical predictions of flow effects on intestinal and systemic availability in physiologically based pharmacokinetic intestine models: the traditional model, segregated flow model, and QGut model.
    Pang KS; Chow EC
    Drug Metab Dispos; 2012 Oct; 40(10):1869-77. PubMed ID: 22745334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Segmental intestinal transporters and metabolic enzymes on intestinal drug absorption.
    Tam D; Tirona RG; Pang KS
    Drug Metab Dispos; 2003 Apr; 31(4):373-83. PubMed ID: 12642462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of intestinal first-pass drug metabolism.
    Yang J; Jamei M; Yeo KR; Tucker GT; Rostami-Hodjegan A
    Curr Drug Metab; 2007 Oct; 8(7):676-84. PubMed ID: 17979655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A convenient method for estimating the quantity of drug eliminated by the routes other than hepatic metabolism and renal excretion and the fraction of drug that reaches the "first pass" after oral administration.
    Berezhkovskiy LM
    J Pharm Sci; 2006 Apr; 95(4):828-33. PubMed ID: 16489605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.